|
| | 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid Basic information |
| Product Name: | 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid | | Synonyms: | 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid;1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic acid, 13-oxo-;JYSLQCINSTWPIO-UHFFFAOYSA-N;Gadoteridol Impurity 5;Gadoteridol Impurity 2 | | CAS: | 229312-33-8 | | MF: | C13H22N4O5 | | MW: | 314.34 | | EINECS: | | | Product Categories: | | | Mol File: | 229312-33-8.mol | ![13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid Structure](CAS/20150408/GIF/229312-33-8.gif) |
| | 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid Chemical Properties |
| Melting point | 140-144°C | | storage temp. | Refrigerator | | solubility | Methanol (Slightly), Water (Slightly) | | form | Solid | | color | White to Off-White |
| | 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid Usage And Synthesis |
| Uses | 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid is an impurity in the synthesis of Gadoteridol, an MRI contrast chelating agent. |
| | 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid Preparation Products And Raw materials |
|